Effects of Institutional Experience on Plan Quality in Stereotactic Radiotherapy Using HyperArc for Brain Metastases

Sayaka Kihara1,2, Shingo Ohira3,4, Naoyuki Kanayama3

  • 1Department of Radiation Oncology, Osaka International Cancer Institute, Osaka, Japan; sayaka.kihara@oici.jp.

In Vivo (Athens, Greece)
|December 31, 2024
PubMed
Summary

Institutional experience significantly improved HyperArc (HA) stereotactic radiotherapy (SRT) plan quality for brain metastases. Later treatment groups showed better gross tumor volume (GTV) doses and brain sparing, indicating accumulated expertise enhances automated planning outcomes.

Related Concept Videos